Panama vs United Arab Emirates: Access to anti-retroviral drugs, male
Panama
72.0%
in 2024
United Arab Emirates
73.0%
in 2024
Panama rank
65th
United Arab Emirates rank
62nd
Access to anti-retroviral drugs, male over time
- Panama
- United Arab Emirates
How they compare
United Arab Emirates currently reports 73.0% against 72.0% in Panama, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Panama ahead.
Panama ranks 65th and United Arab Emirates ranks 62nd of 141 countries.
Across the 3 decades both report, Panama averaged higher in 1 and United Arab Emirates in 2.
Head to head by decade
| Decade | Panama | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.6% | 18.4% | 3.8% | United Arab Emirates |
| 2010s | 41.7% | 25.4% | 16.3% | Panama |
| 2020s | 64.6% | 71.0% | 6.4% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Panama or United Arab Emirates?
- United Arab Emirates, at 73.0% against 72.0% in Panama as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Panama and United Arab Emirates?
- 1.0%, with United Arab Emirates ahead.
- How many years of comparable data are there for Panama and United Arab Emirates?
- 25 years are reported by both, from 2000 to 2024.
- How do Panama and United Arab Emirates rank globally for access to anti-retroviral drugs, male?
- Panama ranks 65th and United Arab Emirates ranks 62nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.